journal
Journals Journal of Clinical Endocrinol...

Journal of Clinical Endocrinology and Metabolism

https://read.qxmd.com/read/38701358/cost-effectiveness-of-genetic-testing-of-endocrine-tumor-patients-using-a-comprehensive-hereditary-cancer-gene-panel
#1
JOURNAL ARTICLE
Attila Patócs, Petra Nagy, János Papp, Anikó Bozsik, Bálint Antal, Vince Kornél Grolmusz, Tímea Pócza, Henriett Butz
INTRODUCTION: Heterogenous clinical manifestations, overlapping phenotypes and complex genetic backgrounds are common in patients with endocrine tumors. There are no comprehensive recommendations for genetic testing and counselling of these patients compared to other hereditary cancer syndromes. The application of multigene panel testing is common in clinical genetic laboratories, but their performance for patients with endocrine tumors has not been assessed. METHODS: As a national reference center, we prospectively tested the diagnostic utility and cost-efficiency of a multigene panel covering 113 genes representing genetic susceptibility for solid tumors...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38701346/metabolic-syndrome-and-the-risk-of-kidney-stones-a-large-scale-cohort-study-from-487-860-uk-biobank-participants
#2
JOURNAL ARTICLE
Minghui Liu, Meng Gao, Jian Wu, Zewu Zhu, Jiao Hu, Hequn Chen, Zhiyong Chen, Jinbo Chen
OBJECTIVE: While some studies have suggested an association between metabolic syndrome and kidney stones, the quality and level of evidence in these studies vary. Whether some individual characteristics and clustering of metabolic syndrome traits increase the risk of kidney stones has not been examined in a large-scale prospective cohort. MATERIALS: We conducted a retrospective analysis of data from a prospective cohort of 487,860 UK Biobank participants who were free from kidney stones at baseline...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38701341/can-incorporating-molecular-testing-improve-the-accuracy-of-newborn-screening-for-congenital-adrenal-hyperplasia
#3
JOURNAL ARTICLE
Kyriakie Sarafoglou, Amy Gaviglio, Carrie Wolf, Cindy P Lorentz, Aida Lteif, Jennifer Kyllo, Gretchen Radloff, Zachary Detwiler, Carla D Cuthbert, James S Hodges, Scott D Grosse, Christopher N Greene, Suzanne Cordovado
BACKGROUND: Single-tier newborn screening (NBS) for CAH using 17-hydroxyprogesterone (17OHP) measured by fluoroimmunoassay (FIA) in samples collected at 24-48 hours produces a high false-positive rate (FPR). 2nd tier steroid testing can reduce the FPR and has been widely implemented. We investigated the accuracy of an alternative multi-tier CAH NBS protocol that incorporates molecular testing of the CYP21A2 gene and reduces the 1st tier 17OHP cutoff to minimize missed cases. METHODS: Created a Minnesota-specific CYP21A2 pathogenic variants panel; develop a rapid, high-throughput multiplex, allele-specific-primer-extension assay; perform 1-year retrospective analysis of Minnesota NBS results comparing metrics between a conventional steroid-based two-tier protocol and a molecular-based multi-tier NBS protocol, applied post-hoc...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38701087/the-influence-of-trinucleotide-repeats-in-the-androgen-receptor-gene-on-androgen-related-traits-and-diseases
#4
JOURNAL ARTICLE
Takayoshi Sasako, Yann Ilboudo, Kevin Y H Liang, Yiheng Chen, Satoshi Yoshiji, J Brent Richards
CONTEXT: Trinucleotide repeats in the androgen receptor have been proposed to influence testosterone signaling in men, but the clinical relevance of these trinucleotide repeats remains controversial. OBJECTIVE: To examine how androgen receptor trinucleotide repeat lengths affect androgen-related traits and disease risks and whether they influence the clinical importance of circulating testosterone levels. METHODS: We quantified CAG and GGC repeat lengths in the androgen receptor (AR) gene of European-ancestry male participants in UK Biobank from whole-genome and whole-exome sequence data using ExpansionHunter, and tested associations with androgen-related traits and diseases...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38700099/thyroid-dysfunction-risk-after-iodinated-contrast-media-administration-a-prospective-longitudinal-cohort-analysis
#5
JOURNAL ARTICLE
Seo Young Sohn, Kosuke Inoue, Muhammad T Bashir, Jesse W Currier, Natalia V Neverova, Ramin Ebrahimi, Connie M Rhee, Martin L Lee, Angela M Leung
CONTEXT: Iodinated contrast media (ICM) is a common source of excess iodine in medical settings, given the common use of iodinated radiologic procedures. OBJECTIVE: To determine the long-term risks of thyroid dysfunction following iodinated contrast administration in a prospective study. DESIGN, SETTING, PARTICIPANTS: A longitudinal cohort study was conducted of patients in the U.S. Veterans Affairs medical system who received ICM. MAIN OUTCOME MEASURES: Serum thyroid function, thyroid antibody, and inflammatory markers were measured at baseline...
May 3, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38695547/improvement-of-%C3%AE-cell-function-after-switching-from-dpp-4-inhibitors-to-oral-semaglutide-switch-sema2-post-hoc-analysis
#6
JOURNAL ARTICLE
Hiroshi Nomoto, Sho Furusawa, Hiroki Yokoyama, Yuka Suzuki, Rimi Izumihara, Yuki Oe, Kiyohiko Takahashi, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Jun Takeuchi, Yoshio Kurihara, Akinobu Nakamura, Tatsuya Atsumi
CONTEXT: Whether continuation of dipeptidyl peptidase-4 inhibitors (DPP-4is) or switching to oral semaglutide is more beneficial for β-cell function is unclear. OBJECTIVE: To assess the efficacy of switching from DPP-4is to oral semaglutide for β-cell function compared with DPP-4i continuation. METHODS: Post hoc analysis of SWITCH-SEMA 2, a multicenter prospective randomized controlled trial on the switch to oral semaglutide vs DPP-4i continuation without dose adjustment for 24 weeks in subjects with type 2 diabetes treated with DPP-4is, was conducted...
May 2, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38693775/risk-assessment-of-diabetes-mellitus-during-and-after-pregnancy-in-women-with-prolactinomas
#7
JOURNAL ARTICLE
Roberta Scairati, Renata S Auriemma, Sara Di Meglio, Guendalina Del Vecchio, Rosa Pirchio, Chiara Graziadio, Claudia Pivonello, Rosario Pivonello, Annamaria Colao
CONTEXT: Prolactin (PRL) is a crucial mediator of gluco-insulinemic metabolism. OBJECTIVE: Dissecting glucose metabolism during and after pregnancy in patients with prolactinomas. METHODS: 52 patients treated with cabergoline (CAB) were evaluated before conception, during pregnancy and up to 10 years after delivery. During pregnancy, CAB was discontinued, while it was restarted in 57.7 % of patients after delivery, due to recurrent hyperprolactinemia (RH)...
May 2, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38686701/the-association-of-cardiometabolic-diet-and-lifestyle-parameters-with-plasma-glucagon-like-peptide-1-an-imi-direct-study
#8
JOURNAL ARTICLE
Rebeca Eriksen, Margaret C White, Adem Y Dawed, Isabel Garcia Perez, Joram M Posma, Mark Haid, Sapna Sharma, Cornelia Prehn, Louise E Thomas, Robert W Koivula, Roberto Bizzotto, Andrea Mari, Giuseppe N Giordano, Imre Pavo, Jochen M Schwenk, Federico De Masi, Konstantinos D Tsirigos, Søren Brunak, Ana Viñuela, Anubha Mahajan, Timothy J McDonald, Tarja Kokkola, Femke Rutters, Joline Beulens, Mirthe Muilwijk, Marieke Blom, Petra Elders, Tue H Hansen, Juan Fernandez-Tajes, Angus Jones, Chris Jennison, Mark Walker, Mark I McCarthy, Oluf Pedersen, Hartmut Ruetten, Ian Forgie, Jens J Holst, Henrik S Thomsen, Martin Ridderstråle, Jimmy D Bell, Jerzy Adamski, Paul W Franks, Torben Hansen, Elaine Holmes, Gary Frost, Ewan R Pearson
CONTEXT: The role of glucagon-like peptide-1(GLP-1) in Type 2 diabetes (T2D) and obesity is not fully understood. OBJECTIVE: We investigate the association of cardiometabolic, diet and lifestyle parameters on fasting and postprandial GLP-1 in people at risk of, or living with, T2D. METHOD: We analysed cross-sectional data from the two Innovative Medicines Initiative (IMI) Diabetes Research on Patient Stratification (DIRECT) cohorts, cohort 1(n=2127) individuals at risk of diabetes; cohort 2 (n=789) individuals with new-onset of T2D...
April 30, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38686666/basal-hyperglycemia-contributes-more-than-fifty-percent-to-time-in-range-in-pregnant-women-with-type-1-diabetes
#9
JOURNAL ARTICLE
Ping Ling, Daizhi Yang, Chaofan Wang, Xueying Zheng, Sihui Luo, Xubin Yang, Hongrong Deng, Wen Xu, Jinhua Yan, Jianping Weng
AIMS: To evaluate the relative contribution of basal hyperglycemia (BHG) and postprandial hyperglycemia (PHG) to the time in range (TIR) categories and adverse pregnancy outcomes in pregnant women with type 1 diabetes mellitus (T1DM). MATERIALS AND METHODS: This observational study included 112 pregnancies with T1DM from the CARNATION study who wore continuous glucose monitoring (CGM) devices during pregnancy. The data from CGM were analyzed for TIR (range, 3.5-7...
April 30, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38686504/influence-of-thyroglobulin-tg-autoantibodies-on-tg-levels-measured-by-different-methodologies-ima-lc-ms-ms-and-ria
#10
JOURNAL ARTICLE
Ivana Petrovic, Jonathan LoPresti, Shireen Fatemi, Andrew Gianoukakis, Kenneth Burman, Cristiane J Gomez-Lima, Caroline T Nguyen, Carole Ann Spencer
CONTEXT: Serum thyroglobulin (Tg) measured by Immunometric assays (IMA) is prone to underestimation due to Tg autoantibody (TgAb) interference, often prompting reflex Tg measurement by liquid chromatography/tandem mass spectrometry (MS) or radioimmunoassay (RIA). OBJECTIVE: IMA, MS and RIA methodologies were used to measure serum Tg in TgAb-negative (TgAb-) and TgAb-positive (TgAb+) patients with either distant metastatic thyroid cancer (DTC) or hyperthyroidism (HY) - patients in whom a detectable serum Tg would be expected...
April 30, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38679750/from-bench-to-bedside-how-artificial-intelligence-is-changing-thyroid-nodule-diagnostics
#11
JOURNAL ARTICLE
Vivek R Sant, Ashwath Radhachandran, Vedrana Ivezic, Denise T Lee, Masha J Livhits, James X Wu, Rinat Masamed, Corey W Arnold, Michael W Yeh, William Speier
CONTEXT: Use of artificial intelligence (AI) to predict clinical outcomes in thyroid nodule diagnostics has grown exponentially over the past decade. The greatest challenge is in understanding the best model to apply to one's own patient population, and how to operationalize such a model in practice. EVIDENCE ACQUISITION: A literature search of PubMed and IEEE Xplore was conducted for English language publications between January 1, 2015 and January 1, 2023 studying diagnostic tests on suspected thyroid nodules that utilized AI...
April 29, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38662803/prepubertal-children-with-obesity-have-high-free-igf-1-levels-and-accelerated-growth-despite-reduced-pappalysin-levels
#12
JOURNAL ARTICLE
Álvaro Martín-Rivada, Gabriel Á Martos-Moreno, Santiago Guerra-Cantera, Ana Campillo-Calatayud, Claus Oxvig, Jan Frystyk, Julie A Chowen, Vicente Barrios, Jesús Argente
BACKGROUND: Prepubertal children with obesity frequently have enhanced growth, accelerated skeletal maturation and changes in the GH-IGF axis. However, the involvement of pappalysins (PAPP-A, PAPP-A2) and stanniocalcins (STC1, STC2) as regulators of IGF bioavailability has not been studied in obesity. OBJECTIVE: We aimed to determine the effects of childhood obesity and weight reduction on serum levels of PAPP-A, PAPP-A2, STC1 and STC2 and their relationship with IGF bioavailability, growth, and other components of the GH-IGF system...
April 25, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38661205/patient-reported-outcomes-in-autosomal-dominant-osteopetrosis-findings-from-the-osteopetrosis-registry-study
#13
JOURNAL ARTICLE
Lynda E Polgreen, Eva Villa-Lopez, Liz Chen, Ziyue Liu, Amy Katz, Corinne Parks-Schenck, Marian Hart, Erik A Imel, Michael J Econs
CONTEXT: Autosomal dominant osteopetrosis (ADO) is a rare sclerotic bone disease characterized by impaired osteoclast activity, resulting in high bone mineral density and skeletal fragility. The full phenotype and disease burden on patients' daily lives has not been systematically measured. OBJECTIVE: We developed an online registry to ascertain population-based data on the spectrum and rate of progression of disease and to identify relevant patient centered outcomes that could be used to measure treatment effects and guide the design of future clinical trials...
April 25, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38661084/long-term-cumulative-incidence-of-clinically-diagnosed-retinopathy-in-the-finnish-diabetes-prevention-study
#14
JOURNAL ARTICLE
Kai Kaarniranta, Mikko Valtanen, Sirkka Keinänen-Kiukaanniemi, Jaakko Tuomilehto, Jaana Lindström, Matti Uusitupa
CONTEXT: Lifestyle intervention reduces the incidence of type 2 diabetes (T2D) in people with impaired glucose tolerance. OBJECTIVE: To find out whether participation in the earlier lifestyle intervention had an effect on the occurrence of clinically diagnosed retinopathy during a median of 22 years of follow-up time. METHODS: The study included 505 individuals from the Finnish Diabetes Prevention Study (DPS) (mean 55, range 40-64 years at the onset of the study) with impaired glucose tolerance who were originally randomized into the intervention (weight loss, healthy diet and physical activity (N=257) and usual care control groups (N=248)...
April 25, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38661071/clinical-activity-of-selpercatinib-in-ret-mutant-pheochromocytoma
#15
JOURNAL ARTICLE
Barbara Deschler-Baier, Bhavana Konda, Erminia Massarelli, Mimi I Hu, Lori J Wirth, Xiaojian Xu, Jennifer Wright, Roderick J Clifton-Bligh
INTRODUCTION: Activating RET alterations have been reported in a variety of solid tumors, including pheochromocytoma where they occur both sporadically and as part of familial multiple endocrine neoplasia type 2 (MEN2) syndromes. Selpercatinib is a first-in-class, highly selective, and potent small molecule RET kinase inhibitor that has demonstrated marked and durable anti-tumor activity in diverse RET-activated solid tumors in the LIBRETTO-001 study (NCT03157128). METHODS: We describe the first six pheochromocytoma cases treated with selpercatinib in the LIBRETTO-001 study...
April 25, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38661044/a-body-shape-index-as-a-simple-anthropometric-marker-of-abdominal-obesity-and-risk-of-cardiovascular-events
#16
JOURNAL ARTICLE
Masato Kajikawa, Tatsuya Maruhashi, Shinji Kishimoto, Takayuki Yamaji, Takahiro Harada, Yusuke Saito, Aya Mizobuchi, Shunsuke Tanigawa, Yukiko Nakano, Kazuaki Chayama, Chikara Goto, Farina Mohamad Yusoff, Ayumu Nakashima, Yukihito Higashi
BACKGROUND: A Body Shape Index (ABSI) has been reported to have associations with cardiovascular risk factors. However, there is no information on the association between ABSI and incidence of cardiovascular events. METHODS: We investigated the associations between ABSI and first major cardiovascular events (death from cardiovascular disease, nonfatal acute coronary syndrome, and nonfatal stroke) in 1857 subjects from the database of Flow-Mediated Dilation Japan registry and from Hiroshima University Vascular Function registry...
April 25, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38661006/colorectal-cancer-and-subsequent-diabetes-risk-a-population-based-cohort-study-in-taiwan
#17
JOURNAL ARTICLE
Hsin-Yin Hsu, Yih-Jong Chern, Min-Shu Hsu, Tzu-Lin Yeh, Ming-Chieh Tsai, Jing-Rong Jhuang, Cheng-Tzu Hsieh, Chun-Ju Chiang, Wen-Chung Lee, Lee-Ching Hwang, Kuo-Liong Chien
CONTEXT: The association between colorectal cancer (CRC) and new-onset diabetes mellitus remains unclear. OBJECTIVE: To examine the association between CRC and the risk of subsequent diabetes mellitus and to further investigate the impact of chemotherapy on diabetes mellitus risk in CRC. DESIGN: A nationwide cohort study. METHODS: Using the Taiwan Cancer Registry Database (2007-2018) linked with health databases, 86,268 patients with CRC and an equal propensity score-matched cohort from the general population were enrolled...
April 25, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38656317/establishment-of-human-pituitary-neuroendocrine-tumor-derived-organoid-and-its-pilot-application-for-drug-screening
#18
JOURNAL ARTICLE
Run Cui, Hao Duan, Wanming Hu, Chang Li, Sheng Zhong, Lun Liang, Siyu Chen, Hongrong Hu, Zhenqiang He, Zhenning Wang, Xiaoyu Guo, Zexin Chen, Cong Xu, Yu Zhu, Yinsheng Chen, Ke Sai, Qunying Yang, Chengcheng Guo, Yonggao Mou, Xiaobing Jiang
CONTEXT: Precision medicine for pituitary neuroendocrine tumors (PitNETs) is limited by the lack of reliable research models. OBJECTIVE: To generate patient-derived organoids (PDOs), which could serve as a platform for personalized drug screening for PitNET patients. DESIGN: From July 2019 to May 2022, a total of 32 human PitNET specimens were collected for the establishment of organoids with an optimized culture protocol. SETTING: This study was conducted at Sun Yat-Sen University Cancer Center...
April 24, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38655872/inflammation-based-scores-in-patients-with-pheochromocytoma
#19
JOURNAL ARTICLE
Chiara Parazzoli, Alessandro Prete, Vittoria Favero, Carmen Aresta, Valentina Pucino, John Ayuk, Miriam Asia, Yasir S Elhassan, Iacopo Chiodini, Cristina L Ronchi
BACKGROUND: Pheochromocytoma is associated with systemic inflammation, but the underlying mechanisms are unclear. Therefore, we investigated the relationship between plasma metanephrine levels and haematological parameters - as a surrogate of inflammation - in patients with pheochromocytoma and the influence of preoperative α-blockade treatment. DESIGN AND METHODS: We retrospectively studied 68 patients with pheochromocytoma who underwent adrenalectomy (median age 53 years, 64...
April 24, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38654471/identification-of-eukaryotic-translation-initiation-factor-4b-as-a-novel-candidate-gene-for-congenital-hypothyroidism
#20
JOURNAL ARTICLE
Feng Sun, Rui-Jia Zhang, Ya Fang, Cheng-Yan Yan, Chang-Run Zhang, Feng-Yao Wu, Rui-Meng Yang, Bing Han, Huai-Dong Song, Shuang-Xia Zhao
CONTEXT: Congenital hypothyroidism (CH) is the most common endocrine disorder in neonates, but its etiology is still poorly understood. OBJECTIVE: We performed whole exome sequencing to identify novel causative gene for CH and functional studies to validate its role in the occurrence of CH. METHODS: Whole exome sequencing in 98 CH patients not harboring known CH candidate genes and bioinformatic analysis were performed. Functional analysis was performed using morpholino, a synthetic short antisense oligonucleotide that contains 25 DNA bases on a methylene morpholine backbone, in zebrafish and CRISPR‒Cas9-mediated gene knockout in mice...
April 24, 2024: Journal of Clinical Endocrinology and Metabolism
journal
journal
20145
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.